• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

安卡拉痘苗病毒改良疫苗作为暴露前和暴露后预防非人灵长类动物模型中猴痘性传播的有效性。

Efficacy of modified-vaccinia Ankara vaccine as pre- and post-exposure prophylaxis against monkeypox sexual transmission in non-human primate model.

作者信息

Herate Cécile, Ferrier-Rembert Audrey, Relouzat Francis, Gallouët Anne-Sophie, Pascal Quentin, Letscher Hélène, Cavarelli Mariangela, Dereuddre-Bosquet Nathalie, Gros Wesley, Delache Benoit, Langlois Sébastien, Timera Hawa, Jarjaval Fanny, Bossevot Laetitia, Ludot Camille, Brua Catherine, Lechemia Maxence, Ferraris Olivier, Silvestre Nathalie, Le Grand Roger, Tournier Jean-Nicolas

机构信息

Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Viral Diseases (IMVA-HB/IDMIT), Paris, France.

Microbiology and infectious diseases department, Institut de recherche biomédicale des Armées (IRBA), Brétigny sur Orge Cedex, France.

出版信息

Nat Commun. 2025 Aug 7;16(1):7306. doi: 10.1038/s41467-025-62681-2.

DOI:10.1038/s41467-025-62681-2
PMID:40775237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12332035/
Abstract

The monkeypox virus (MPXV) outbreak of 2022 caused a human disease with unusual epidemiological and clinical features, notably an increase in human-to-human transmission through sexual contact, predominantly among men who have sex with men (MSM). This evolution underscores the need to reassess prevention and control strategies in the context of a sexually transmitted disease. Here, we show that rectal challenge of male cynomolgus macaques with a 2022 clade IIb MPXV isolate mimics sexual transmission, leading to rectal infection, with systemic and male genital tract dissemination and seminal fluid shedding. Vaccination with modified-vaccinia Ankara (MVA) protected the macaques from subsequent rectal MPXV challenge. However, MVA failed to prevent the disease when administered four days post-exposure to MPXV. These findings have a critical impact on outbreak management and highlight the importance of reevaluating MVA post-exposure prophylaxis protocols.

摘要

2022年猴痘病毒(MPXV)疫情引发了一种具有异常流行病学和临床特征的人类疾病,尤其是通过性接触导致的人际传播有所增加,主要发生在男男性行为者(MSM)中。这种演变凸显了在性传播疾病背景下重新评估预防和控制策略的必要性。在此,我们表明,用2022年IIb分支MPXV分离株对雄性食蟹猴进行直肠攻击模拟了性传播,导致直肠感染,并伴有全身和男性生殖道扩散以及精液排出。用安卡拉痘苗病毒(MVA)疫苗接种可保护猕猴免受后续直肠MPXV攻击。然而,在接触MPXV四天后给予MVA未能预防疾病。这些发现对疫情管理具有关键影响,并突出了重新评估MVA暴露后预防方案的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a0/12332035/f8e5f043f558/41467_2025_62681_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a0/12332035/6323df34515b/41467_2025_62681_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a0/12332035/a7d09ecc21f3/41467_2025_62681_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a0/12332035/059dde3ec7ac/41467_2025_62681_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a0/12332035/8a0eeaac81b0/41467_2025_62681_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a0/12332035/2fe7d6a6d80d/41467_2025_62681_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a0/12332035/f8e5f043f558/41467_2025_62681_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a0/12332035/6323df34515b/41467_2025_62681_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a0/12332035/a7d09ecc21f3/41467_2025_62681_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a0/12332035/059dde3ec7ac/41467_2025_62681_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a0/12332035/8a0eeaac81b0/41467_2025_62681_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a0/12332035/2fe7d6a6d80d/41467_2025_62681_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a0/12332035/f8e5f043f558/41467_2025_62681_Fig6_HTML.jpg

相似文献

1
Efficacy of modified-vaccinia Ankara vaccine as pre- and post-exposure prophylaxis against monkeypox sexual transmission in non-human primate model.安卡拉痘苗病毒改良疫苗作为暴露前和暴露后预防非人灵长类动物模型中猴痘性传播的有效性。
Nat Commun. 2025 Aug 7;16(1):7306. doi: 10.1038/s41467-025-62681-2.
2
Correlation between microneutralization test and a multiplexed immunoassay for evaluation of monkeypox and vaccinia virus antibodies before and after smallpox vaccination.在天花疫苗接种前后,用于评估猴痘病毒和牛痘病毒抗体的微量中和试验与多重免疫测定之间的相关性。
Front Immunol. 2025 Jun 23;16:1585284. doi: 10.3389/fimmu.2025.1585284. eCollection 2025.
3
Characterization and comparison of immunity against MPXV for individuals infected with MPXV or vaccinated with modified vaccinia Ankara vaccines.感染猴痘病毒(MPXV)或接种安卡拉痘苗病毒(modified vaccinia Ankara)疫苗的个体对MPXV免疫的特征分析与比较
J Immunol. 2025 Feb 1;214(2):211-222. doi: 10.1093/jimmun/vkae031.
4
Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies: A Review.猴痘临床特征、诊断方法及治疗策略:综述。
JAMA. 2024 Nov 19;332(19):1652-1662. doi: 10.1001/jama.2024.21091.
5
Tiantan vaccinia virus-based vaccine with promising safety provides sustained protection against mpox in non-human primates.基于天坛痘苗病毒的疫苗安全性良好,能在非人灵长类动物中提供针对猴痘的持续保护。
Nat Commun. 2025 Aug 5;16(1):7183. doi: 10.1038/s41467-025-62594-0.
6
Exploring monkeypox virus antibody levels: insights from human immunological research.探索猴痘病毒抗体水平:来自人体免疫学研究的见解
Virol J. 2025 May 31;22(1):175. doi: 10.1186/s12985-025-02748-0.
7
Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response.作为猴痘预防措施使用的MVA-BN疫苗的免疫原性:一项前瞻性、单中心队列研究及反应的转录组预测因子分析。
Lancet Microbe. 2025 Jun;6(6):101045. doi: 10.1016/j.lanmic.2024.101045. Epub 2025 Apr 23.
8
A multivalent mRNA vaccine elicits robust immune responses and confers protection in a murine model of monkeypox virus infection.一种多价mRNA疫苗在猴痘病毒感染的小鼠模型中引发了强烈的免疫反应并提供了保护。
Nat Commun. 2025 Aug 9;16(1):7373. doi: 10.1038/s41467-025-61699-w.
9
Multiple gene-deletion vaccinia virus Tiantan strain against mpox.针对猴痘的多基因缺失痘苗病毒天坛株
Virol J. 2025 Jan 25;22(1):17. doi: 10.1186/s12985-025-02629-6.
10
Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study.德国高危人群中MVA-BN痘苗接种预防猴痘的安全性和有效性(SEMVAc和TEMVAc):一项前瞻性与回顾性队列联合研究
Lancet Infect Dis. 2025 Jul;25(7):775-787. doi: 10.1016/S1473-3099(25)00018-0. Epub 2025 Mar 18.

本文引用的文献

1
Mpox unveiled: Global epidemiology, treatment advances, and prevention strategies.猴痘揭秘:全球流行病学、治疗进展与预防策略
One Health. 2025 Apr 10;20:101030. doi: 10.1016/j.onehlt.2025.101030. eCollection 2025 Jun.
2
Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.在猴痘疫情期间,为年龄≥18岁有猴痘感染风险人群使用JYNNEOS(天花和猴痘活病毒非复制疫苗):美国免疫实践咨询委员会的建议,2023年
MMWR Morb Mortal Wkly Rep. 2025 Jun 19;74(22):385-392. doi: 10.15585/mmwr.mm7422a3.
3
Current status of next-generation vaccines against mpox virus: a scoping review.
抗猴痘病毒的下一代疫苗的现状:一项范围综述
Front Pharmacol. 2025 Apr 28;16:1533533. doi: 10.3389/fphar.2025.1533533. eCollection 2025.
4
The emergence of a novel mpox virus strain (clade Ib) in Central Africa: A global public health concern.中非出现新型猴痘病毒毒株(Ib分支):全球公共卫生问题。
J Infect Public Health. 2025 Jul;18(7):102781. doi: 10.1016/j.jiph.2025.102781. Epub 2025 Apr 16.
5
Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study.德国高危人群中MVA-BN痘苗接种预防猴痘的安全性和有效性(SEMVAc和TEMVAc):一项前瞻性与回顾性队列联合研究
Lancet Infect Dis. 2025 Jul;25(7):775-787. doi: 10.1016/S1473-3099(25)00018-0. Epub 2025 Mar 18.
6
Characterization and comparison of immunity against MPXV for individuals infected with MPXV or vaccinated with modified vaccinia Ankara vaccines.感染猴痘病毒(MPXV)或接种安卡拉痘苗病毒(modified vaccinia Ankara)疫苗的个体对MPXV免疫的特征分析与比较
J Immunol. 2025 Feb 1;214(2):211-222. doi: 10.1093/jimmun/vkae031.
7
Genomic and Antigenic Differences Between Monkeypox Virus and Vaccinia Vaccines: Insights and Implications for Vaccinology.猴痘病毒与牛痘疫苗之间的基因组和抗原差异:疫苗学的见解与启示
Int J Mol Sci. 2025 Feb 8;26(4):1428. doi: 10.3390/ijms26041428.
8
Short-Lived Neutralizing Antibody Responses to Monkeypox Virus in Smallpox Vaccine-Naive Persons after JYNNEOS Vaccination.在接种JYNNEOS疫苗后,未接种过天花疫苗的人群对猴痘病毒产生的短期中和抗体反应。
Emerg Infect Dis. 2025 Feb;31(2):237-245. doi: 10.3201/eid3102.241300. Epub 2024 Jan 10.
9
Monkeypox Virus Infection Stimulates a More Robust and Durable Neutralizing Antibody Response Compared to Modified Vaccinia Virus Ankara Vaccination.与安卡拉改良痘苗病毒疫苗接种相比,猴痘病毒感染可刺激产生更强健且持久的中和抗体反应。
J Infect Dis. 2025 Apr 15;231(4):1069-1073. doi: 10.1093/infdis/jiae515.
10
Decline of Mpox Antibody Responses After Modified Vaccinia Ankara-Bavarian Nordic Vaccination.安卡拉痘苗病毒-巴伐利亚北欧公司疫苗接种后猴痘抗体反应的下降
JAMA. 2024 Nov 19;332(19):1669-1672. doi: 10.1001/jama.2024.20951.